ADDvise Group AB A
ADDvise Group AB (publ) supplies medical devices, equipment, and consumables to public and private laboratories and research facilities, healthcare, and pharmaceuticals in North America, Europe, South America, Sweden, and internationally. The company provides laboratory furniture, protective ventilation systems, climate-controlled clean rooms, and laboratory equipment; and develops and supplies m… Read more
ADDvise Group AB A (ADDV-A) - Net Assets
Latest net assets as of September 2025: Skr1.11 Billion SEK
Based on the latest financial reports, ADDvise Group AB A (ADDV-A) has net assets worth Skr1.11 Billion SEK as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr2.92 Billion) and total liabilities (Skr1.81 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr1.11 Billion |
| % of Total Assets | 38.03% |
| Annual Growth Rate | 38.48% |
| 5-Year Change | 817.09% |
| 10-Year Change | 19537.82% |
| Growth Volatility | 235.73 |
ADDvise Group AB A - Net Assets Trend (2007–2024)
This chart illustrates how ADDvise Group AB A's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for ADDvise Group AB A (2007–2024)
The table below shows the annual net assets of ADDvise Group AB A from 2007 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | Skr835.00 Million | +36.17% |
| 2023-12-31 | Skr613.20 Million | +24.41% |
| 2022-12-31 | Skr492.87 Million | +99.32% |
| 2021-12-31 | Skr247.28 Million | +171.58% |
| 2020-12-31 | Skr91.05 Million | +8.21% |
| 2019-12-31 | Skr84.14 Million | +63.67% |
| 2018-12-31 | Skr51.41 Million | +4.90% |
| 2017-12-31 | Skr49.01 Million | +6.44% |
| 2016-12-31 | Skr46.04 Million | +982.88% |
| 2015-12-31 | Skr4.25 Million | -71.42% |
| 2014-12-31 | Skr14.88 Million | +34.36% |
| 2013-12-31 | Skr11.07 Million | +14.79% |
| 2012-12-31 | Skr9.65 Million | +4.37% |
| 2011-12-31 | Skr9.24 Million | +114.70% |
| 2010-12-31 | Skr4.30 Million | +85.24% |
| 2008-12-31 | Skr2.32 Million | -29.49% |
| 2007-12-31 | Skr3.30 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to ADDvise Group AB A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 13934.2% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Skr271.00 Million | 32.46% |
| Common Stock | Skr19.90 Million | 2.38% |
| Other Comprehensive Income | Skr37.90 Million | 4.54% |
| Other Components | Skr506.20 Million | 60.62% |
| Total Equity | Skr835.00 Million | 100.00% |
ADDvise Group AB A Competitors by Market Cap
The table below lists competitors of ADDvise Group AB A ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Serviceware SE
F:SJJ
|
$52.13 Million |
|
Handok
KO:002390
|
$52.14 Million |
|
Lihtai Construction Enterprise Co Ltd
TWO:5520
|
$52.15 Million |
|
Entech SE SAS
PA:ALESE
|
$52.16 Million |
|
UNICOMMERCE ESOLUTIONS LIMITED
NSE:UNIECOM
|
$52.10 Million |
|
TuHURA Biosciences Inc
NASDAQ:HURA
|
$52.08 Million |
|
Big Shopping Centers Ltd
TA:BIG
|
$52.08 Million |
|
Tekcore Co. Ltd
TWO:3339
|
$52.05 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ADDvise Group AB A's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 613,200,000 to 835,000,000, a change of 221,800,000 (36.2%).
- Net income of 90,000,000 contributed positively to equity growth.
- Share repurchases of 100,100,000 reduced equity.
- New share issuances of 100,100,000 increased equity.
- Other comprehensive income increased equity by 36,000,000.
- Other factors increased equity by 95,800,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr90.00 Million | +10.78% |
| Share Repurchases | Skr100.10 Million | -11.99% |
| Share Issuances | Skr100.10 Million | +11.99% |
| Other Comprehensive Income | Skr36.00 Million | +4.31% |
| Other Changes | Skr95.80 Million | +11.47% |
| Total Change | Skr- | 36.17% |
Book Value vs Market Value Analysis
This analysis compares ADDvise Group AB A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.41x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 0.89x to 0.41x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2007-12-31 | Skr1.93 | Skr1.72 | x |
| 2008-12-31 | Skr1.36 | Skr1.72 | x |
| 2010-12-31 | Skr1.18 | Skr1.72 | x |
| 2011-12-31 | Skr1.64 | Skr1.72 | x |
| 2012-12-31 | Skr0.90 | Skr1.72 | x |
| 2013-12-31 | Skr0.71 | Skr1.72 | x |
| 2014-12-31 | Skr1.27 | Skr1.72 | x |
| 2015-12-31 | Skr0.18 | Skr1.72 | x |
| 2016-12-31 | Skr1.04 | Skr1.72 | x |
| 2017-12-31 | Skr0.76 | Skr1.72 | x |
| 2018-12-31 | Skr1.19 | Skr1.72 | x |
| 2019-12-31 | Skr0.89 | Skr1.72 | x |
| 2020-12-31 | Skr0.80 | Skr1.72 | x |
| 2021-12-31 | Skr1.73 | Skr1.72 | x |
| 2022-12-31 | Skr2.78 | Skr1.72 | x |
| 2023-12-31 | Skr3.30 | Skr1.72 | x |
| 2024-12-31 | Skr4.24 | Skr1.72 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently ADDvise Group AB A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 10.78%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.39%
- • Asset Turnover: 0.48x
- • Equity Multiplier: 4.13x
- Recent ROE (10.78%) is above the historical average (-25.92%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2007 | 33.40% | 3.30% | 2.83x | 3.57x | Skr771.40K |
| 2008 | -41.78% | -2.83% | 2.66x | 5.56x | Skr-1.20 Million |
| 2010 | -110.82% | -21.41% | 1.04x | 5.00x | Skr-5.20 Million |
| 2011 | -2.98% | -0.54% | 2.16x | 2.53x | Skr-1.20 Million |
| 2012 | -37.27% | -3.58% | 1.48x | 7.03x | Skr-4.56 Million |
| 2013 | -41.23% | -3.80% | 1.37x | 7.89x | Skr-5.67 Million |
| 2014 | -32.00% | -3.45% | 0.83x | 11.19x | Skr-6.25 Million |
| 2015 | -261.01% | -7.57% | 1.14x | 30.33x | Skr-11.52 Million |
| 2016 | 0.81% | 0.19% | 0.87x | 4.89x | Skr-4.22 Million |
| 2017 | -11.90% | -2.42% | 0.86x | 5.69x | Skr-10.70 Million |
| 2018 | -2.09% | -0.40% | 0.92x | 5.68x | Skr-6.19 Million |
| 2019 | 4.83% | 1.16% | 0.97x | 4.29x | Skr-4.34 Million |
| 2020 | 16.09% | 4.08% | 1.04x | 3.80x | Skr5.54 Million |
| 2021 | 1.13% | 0.60% | 0.44x | 4.32x | Skr-21.92 Million |
| 2022 | 16.45% | 8.52% | 0.48x | 3.99x | Skr31.81 Million |
| 2023 | 16.88% | 7.54% | 0.42x | 5.36x | Skr42.18 Million |
| 2024 | 10.78% | 5.39% | 0.48x | 4.13x | Skr6.50 Million |
Industry Comparison
This section compares ADDvise Group AB A's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $1,118,506,884
- Average return on equity (ROE) among peers: -152.30%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ADDvise Group AB A (ADDV-A) | Skr1.11 Billion | 33.40% | 1.63x | $52.10 Million |
| AddLife AB (publ) (ALIF-B) | $5.31 Billion | 4.75% | 1.46x | $1.43 Billion |
| Biotage AB (BIOT) | $546.66 Million | 13.40% | 0.22x | $787.18 Million |
| Bonesupport Holding AB (BONEX) | $545.18 Million | 44.94% | 0.26x | $869.91 Million |
| Dynavox Group (DYVOX) | $210.60 Million | 23.08% | 5.28x | $782.34 Million |
| iZafe Group AB Series B (IZAFE-B) | $11.19 Million | -38.16% | 0.23x | $12.73 Million |
| Ortivus AB ser. B (ORTI-B) | $226.03 Million | -66.00% | 0.48x | $3.12 Million |
| S2Medical AB (S2M) | $1.66 Million | -1369.60% | 11.91x | $670.81K |
| Stille AB (STIL) | $632.25 Million | 4.21% | 0.27x | $83.41 Million |
| Synsam AB (SYNSAM) | $2.58 Billion | 12.69% | 2.10x | $729.53 Million |